Dr. Parag Shah
Dr. Parag Shah is only the one, in whole of the state of Gujarat possessing the Super-specialty qualifications in Endocrinology.
D.M. (Endocrinology)
Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, July 1997.
D.N.B. (Endocrinology)
National Board of Examinations, New Delhi, May 1997.
Organizing Secretary –ESICON 2015
- Member of European Society of Association of Diabetes, Indian Society of Bone Metabolism and Research
- Active Member of Endocrine Society in India
- Active Member of European Association of study in Diabetes
- Attends all major national and international meetings like American Diabetes Association, Endocrine Society (US), American Association of Clinical Endocrinologist EASD for last eight years.
Dr. Parag Shah is only the one, in whole of the state of Gujarat possessing the Super-specialty qualifications in Endocrinology.
D.M. (Endocrinology)
Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, July 1997.
D.N.B. (Endocrinology)
National Board of Examinations, New Delhi, May 1997.
Organizing Secretary –ESICON 2015
- Member of European Society of Association of Diabetes, Indian Society of Bone Metabolism and Research
- Active Member of Endocrine Society in India
- Active Member of European Association of study in Diabetes
- Attends all major national and international meetings like American Diabetes Association, Endocrine Society (US), American Association of Clinical Endocrinologist EASD for last eight years.
Paper Presentations
- “Bone Metabolism alterations in Acromegaly: Reversibility following surgical treatment” at 26th Annual Conference of Endocrine Society India, Cochin, December 1-3, 1996.
- “Bone Metabolism alterations in Acromegaly: Reversibility following surgical treatment” at 26th Annual Meeting Japanese Society of Bone Mineral Research, Omiya, Japan.
- “Clinical profile and therapeutic outcome of Cushing’s Syndrome” at 26th Annual Conference of Endocrine Society India, Cochin, December 1-3, 1996.
- “Clinical profile and therapeutic outcome of Cushing’s Syndrome” at 3rd Annual Conference of Indian Association of Endocrine Surgeons, Lucknow, December 11-13. 1997.
- “Low Bone turnover state in Hypothyroidism: Reversal following thyroxine therapy” at 15th Annual meeting of Japanese Society of Bone Mineral Research, Omiya, Japan.
- “Markers of bone metabolism in Hyperthyroidism: Reversibility with treatment” at 26th Annual Conference of Endocrine Society of India, Cochin, December 1-3-1996.
- “Low Bone turnover state in Hypothyroidism: Reversal following thyroxine therapy” at 26th Annual Conference of Endocrine Society of India, Lucknow, December 17-19, 1997.
- “Tubercular Addison’s Disease: No improvement in hormonal profile after Anti tubercular therapy” at 25th Annual Conference of Endocrine Society of India, Ahmedabad, December 1-3, 1995.
- “Clinical profile and therapeutic outcome of Cushing Syndrome” at 26th Annual Conference of Endocrine Society of India, Cochin, December 1-3,1996.
- “Clinical profile and therapeutic outcome of Cushing Syndrome” at 3rd Annual Conference of Indian Association of Endocrine Surgeons, Lucknow, December 11-13,1997.
Poster display of interesting cases of “Metabolic Bone Disorders” at 1st CME on Metabolic Bone Disorders, Lucknow, December 16, 1997.
Participated as a Presenter (International)
- ISPAD- OCT 2012, JAPAN
- China Andrology Expert Input Forum on December 8, 2012, HONG KONG
- International Conference on Diabetes and Metabolism- NOV 2012, Seoul, KOREA
Advisory Member of MNCs like
- BI-Lilly
- MSD
- Bayer
- BMS
- Novo-Nordisk
- Sanofi-Aventis
Participated as a Presenter (National)
- ITSCON 2017
- ESICON 2016
- APICON 2016
- ITSCON 2016
- ESICON 2015 (Org secretary),
- ITSCON 2015
- APICON 2015
- ESICON 2014
- ITSCON 2014
- APICON 204
- ESICON 2013
- APICON- FEB 2013, Coimbatore
- RSSDI- OCT 2012, Chennai
- ESICON- DEC 2012, Kolkata
- ESICON- DEC 2011, Pune
- APICON- FEB 2009, Greater Noida
- RSSDI- Nov 2008, Hyderabad
Involved as Principal Investigator in Clinical Trials since 2005
- Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes
- Safety and Efficacy of LY2189265 as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
- A Study to Examine the Effects of LY2189265 Once-Weekly Injection on Glucose Control and Safety in Asian Subjects
- Comparison of Premixed Insulin Lispro Low Mixture and Mid Mixture Regimens with Separate Basal and Bolus Insulin Injections in Patients with Type 2 Diabetes with Inadequate Glycemic Control on Oral Therapy who Consume Light Breakfast
- Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin
- A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
- Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)
- A MultiCentre, Randomised, Double-Blind, Placebo-Controlled Phase IV Trial to Evaluate the Effect of Saxagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischaemic Stroke in Patients With Type 2 Diabetes
- A Randomized, Double-Blind, Placebo and Active-Controlled, 4-Arm, Parallel Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy
- Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
- Niacin/Laropiprant Tablet for South and Southeast Asians With Low HDL at Risk for Cardiovascular Disease
- Study To Assess the dietary Carbohydrate content of Indian diabetic population
- Multifaceted Determinants for Achieving Glycemic Control
- The International Diabetes Management Practice Study (IDMPS)
- Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents
- Comparison of once a week GLP 1 analogue with daily insulin Glargine in patient with T2DM
- A Study to evaluate the Efficacy and Safety of Insulin Detemir against Insulin NPH along With Metformin and Diet/Exercise in Children and Adolescents having Type 2 Diabetes
- Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan (LixiRam)
- Study to evaluate safety and efficacy of growth hormone in adolescent population
